JPS5834120B2 - Method for producing peptides - Google Patents
Method for producing peptidesInfo
- Publication number
- JPS5834120B2 JPS5834120B2 JP10018776A JP10018776A JPS5834120B2 JP S5834120 B2 JPS5834120 B2 JP S5834120B2 JP 10018776 A JP10018776 A JP 10018776A JP 10018776 A JP10018776 A JP 10018776A JP S5834120 B2 JPS5834120 B2 JP S5834120B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- peptide
- reaction
- substituted
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims description 26
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 title description 9
- 238000006243 chemical reaction Methods 0.000 claims description 37
- 239000002253 acid Substances 0.000 claims description 24
- -1 benzhydryloxy group Chemical group 0.000 claims description 19
- 125000006239 protecting group Chemical group 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 108091005804 Peptidases Proteins 0.000 claims description 7
- 102000035195 Peptidases Human genes 0.000 claims description 7
- 235000019833 protease Nutrition 0.000 claims description 7
- 125000000539 amino acid group Chemical group 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000003396 thiol group Chemical class [H]S* 0.000 claims description 2
- 238000000034 method Methods 0.000 description 21
- 150000001412 amines Chemical class 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 15
- 239000004365 Protease Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 108090000526 Papain Proteins 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 13
- 229940055729 papain Drugs 0.000 description 13
- 235000019834 papain Nutrition 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 108010016626 Dipeptides Proteins 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000006340 racemization Effects 0.000 description 6
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 6
- 239000004475 Arginine Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 238000010647 peptide synthesis reaction Methods 0.000 description 5
- 238000007086 side reaction Methods 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 150000003573 thiols Chemical class 0.000 description 5
- 108700023418 Amidases Proteins 0.000 description 4
- 108090000371 Esterases Proteins 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 102000005922 amidase Human genes 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 108010038807 Oligopeptides Proteins 0.000 description 3
- 102000015636 Oligopeptides Human genes 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 108090001069 Chymopapain Proteins 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229960002976 chymopapain Drugs 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 108010054155 lysyllysine Proteins 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WYBVBIHNJWOLCJ-IUCAKERBSA-N Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N WYBVBIHNJWOLCJ-IUCAKERBSA-N 0.000 description 1
- 108090000712 Cathepsin B Proteins 0.000 description 1
- 102000004225 Cathepsin B Human genes 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- KUUUDPTUEOKITK-AWEZNQCLSA-N N-benzoyl-L-tyrosine Chemical compound C([C@@H](C(=O)O)NC(=O)C=1C=CC=CC=1)C1=CC=C(O)C=C1 KUUUDPTUEOKITK-AWEZNQCLSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108090000794 Streptopain Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000003931 anilides Chemical class 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000003248 enzyme activator Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- UMKJQJGLFKDADN-JTQLQIEISA-N n-[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]benzamide Chemical compound NC(N)=NCCC[C@@H](C(N)=O)NC(=O)C1=CC=CC=C1 UMKJQJGLFKDADN-JTQLQIEISA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000007056 transamidation reaction Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【発明の詳細な説明】
本発明はペプチドの製造方法に関し、特に酵素を触媒と
するペプチドの合成方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing a peptide, and particularly to a method for synthesizing a peptide using an enzyme as a catalyst.
従来のペプチドを合成する代表的な方法としては、カル
ボキシル活性法に基づくアジド法、混合酸無水物法、カ
ルボジイミド法、活性エステル法、酸塩化物法を挙げる
ことができる。Typical conventional methods for synthesizing peptides include the azide method based on the carboxyl activity method, the mixed acid anhydride method, the carbodiimide method, the active ester method, and the acid chloride method.
しかし、これらの従来法ではカルボキシル末端アミノ酸
残基におけるラセ□化および副反応の生起、温度制御、
溶媒の選択をはじめ、ア□ノ保護基およびカルボキシル
保護基の性質、アミノ酸残基の官能基に及ぼす影響等を
考慮しなげればならず工業的には種種の問題がある。However, these conventional methods require racemization and side reactions at the carboxyl-terminal amino acid residue, temperature control,
Industrially, various problems arise, including the selection of a solvent, the properties of the □-protecting group and the carboxyl protecting group, and the influence on the functional group of the amino acid residue.
フラグメント縮合法はペプチド合成反応をフラグメント
ごとに分割でき不慮の失敗による損失を最小限にくいと
めることができるばかりでなく工業的には有利な点が多
い。The fragment condensation method not only allows the peptide synthesis reaction to be divided into fragments and minimizes losses due to unexpected failures, but also has many industrial advantages.
しかし、フラグメント縮合法ではラセミ化を起こす可能
性のない唯一のア□ノ酸であるグリシンがカルボキシル
末端に在る場合はよいが、それ以外のアミノ酸の場合に
はラセミ化の生起が避げられないという重大な欠点を有
するものである。However, in the fragment condensation method, it is good if glycine, which is the only amino acid that does not have the possibility of causing racemization, is at the carboxyl terminal, but racemization can be avoided if other amino acids are used. It has the serious drawback that it is not.
ペプチドの製造においてラセミ化を避けることは最も重
要な問題であり、反応中にラセミ化が起った場合には生
酸物を不純にし、不必要な異性体の除去を要し工業的に
は不利となる。Avoiding racemization is the most important issue in the production of peptides, and if racemization occurs during the reaction, it will impure the bioacid and require removal of unnecessary isomers, making it difficult for industrial use. It will be disadvantageous.
前述のペプチド結合形成に関する従来法のうち、アジド
法はラセミ化を起こしにくい唯一の方法である点で利用
価値が高いが他の方法に比較して操作が煩雑であり、ヒ
ドラジド生成工程において副反応が生起し、そのため収
率では必ずしも優れて※※いるとはいえない。Among the conventional methods for forming peptide bonds mentioned above, the azide method has high utility value in that it is the only method that is unlikely to cause racemization, but it is more complicated to operate than other methods, and side reactions occur during the hydrazide production process. occurs, and therefore it cannot necessarily be said that the yield is superior*.
前述の純有機化学的方法とは別にパパインおよびキモト
リプシンによるペプチド結合の生成が報告されている。Apart from the purely organic chemical methods mentioned above, the production of peptide bonds by papain and chymotrypsin has been reported.
(たとえばJ 、 S 、Fruton”Advanc
es in Protein Chemistry ”
Vol 5、Academic Press Jnc
、New York N、 Y、 1949 )この方
法を反応式で示すと次ぎのとおりである。(For example, J, S, Fruton"Advance
es in Protein Chemistry”
Vol 5, Academic Press Jnc
, New York N, Y, 1949) The reaction formula for this method is as follows.
前記(1)〜(3)の従来法において共通している事項
は(II)のいわゆるア□ン成分の末端に結合している
フェニルアミン基は容易には脱離しえない基であり、一
旦形成したペプチドから脱離するには激しい条件下での
加水分解が要求され、結局ペプチド鎖の開裂が生起する
という重大な欠陥があり、したがって、これらの方法を
ペプチド合成に利用することは不可能と考えられていた
。What is common in the conventional methods (1) to (3) above is that the phenylamine group bonded to the end of the so-called ane component in (II) is a group that cannot be easily removed; Separation from the formed peptides requires hydrolysis under harsh conditions, resulting in cleavage of the peptide chain, a major drawback, and therefore, these methods cannot be used for peptide synthesis. It was thought that
また、(4)の方法はトランスアミデージョンおよびト
ランスペプチデーションという副反応を伴い、実用的で
ないことが報告されている〔たとえばRoB。Furthermore, method (4) is reported to be impractical because it involves side reactions of transamidation and transpeptidation [for example, RoB].
Johnston等: J、 Biol 、 Chem
、、185.629(1950)およびJ 、 S 、
Fruton等: J、Biol 。Johnston et al.: J. Biol. Chem.
, 185.629 (1950) and J.S.
Fruton et al.: J. Biol.
Chem 、 204.891(1953))。Chem, 204.891 (1953)).
すなわち(4)の方法ではアミン成分の末端に結合して
いる酸アミド体の第1級アミノ基がパパインによるアミ
ダーゼ作用を促進させるものである。That is, in method (4), the primary amino group of the acid amide compound bonded to the terminal of the amine component promotes the amidase action of papain.
したがって前記の方法は、いずれもア□ン成分の末端カ
ルボキシル基の保護基がアニリドまたは第1級アミドの
結合を形成する場合においてもパパインまたはキモトリ
プシンがペプチド結合形成の触媒作用2有することを示
す学術的意義を有するに止り、オリゴペプチド、ポリペ
プチドの合成に対する可能性を示すものではなかった。Therefore, the above method is based on scientific evidence showing that papain or chymotrypsin has a catalytic action for peptide bond formation even when the protecting group of the terminal carboxyl group of the amine component forms an anilide or primary amide bond. However, it did not indicate the possibility of synthesizing oligopeptides or polypeptides.
本発明はこのような現状に鑑みてなされたものであり、
その目的は所望のオリゴペプチドまたはポリペプチドを
簡単な操作で高純度かつ高収率で製造する方法を提供す
ることである。The present invention was made in view of the current situation, and
The purpose is to provide a method for producing a desired oligopeptide or polypeptide with simple operations and high purity and high yield.
本発明によれば、アミン成分の末端カルボキシル基の保
護基として特定の保護基を導入することにより酵素を利
用するペプチド合成が可能であることが認められた。According to the present invention, it has been recognized that peptide synthesis using an enzyme is possible by introducing a specific protecting group as a protecting group for the terminal carboxyl group of the amine component.
すなわち、本発明はチオールプロテイナーセに属する酵
素の存在下に一般式X−A−OH(式中Xは末端アミノ
基の保護基であり、Aはアミノ酸残基またはペプチド残
基である)で示されるN末端に保護基を有するアミノ酸
またはペプチドと一般式H−B−Y(式中Yは第3級ア
ルコキシ基、置換または非置換ベンジルオキシ基、置換
または非置換ベンジルアミノ基、置換または非置換ベン
ズヒドリルオキシ基および置換または非置換ベンズヒド
リルア□)基よりなる群から選ばれた末端カルボキシル
基の保護基であり、BはAと同一のまたは異なるアミノ
酸残基またはペプチド残基である)で示されるC末端に
保護基を有するアミノ酸またはペプチドとを、反応液の
pHを検出する手段と、反応液のpHを調節するために
酸又は塩基を反応液に添加する手段を備えた反応装置中
で、水性溶液中チオールプロティナーゼが酵素活性を示
すpHの範囲内において反応させることを特徴とする一
般弐X−A−B−Y(式中X、A、B、Yは前記定義と
同一である)で示されるペプチドの製造方法である。That is, the present invention provides an enzyme represented by the general formula Amino acids or peptides having a protecting group at the N-terminus and the general formula H-B-Y (where Y is a tertiary alkoxy group, a substituted or unsubstituted benzyloxy group, a substituted or unsubstituted benzylamino group, a substituted or unsubstituted A protecting group for a terminal carboxyl group selected from the group consisting of a benzhydryloxy group and a substituted or unsubstituted benzhydryloxy group, where B is the same or different amino acid residue or peptide residue as A). An amino acid or a peptide having a protecting group at the C-terminus is added to the reactor in a reaction apparatus equipped with a means for detecting the pH of the reaction solution and a means for adding an acid or base to the reaction solution to adjust the pH of the reaction solution. , general 2 X-A-B-Y (wherein X, A, B, and Y are the same as defined above), characterized in that the reaction is carried out within the pH range in which thiol proteinase exhibits enzymatic activity in an aqueous solution. This is a method for producing the peptide shown in
本発明について概説すると、本発明で使用されるチオー
ルプロティナーゼ(Thiol proteinase
)に属する酵素としては、パパイン(Papain
)、ステムプロメライン(Stem bromelei
n )、フィシン(Ficin )、カテプシンB(C
athepsin B )、キモパパイン(Chymo
papain )およびストレプトコッカルプロティナ
ーゼ(5treptococcalproteinas
e )が例示される。To outline the present invention, thiol proteinase used in the present invention
), papain is an enzyme that belongs to
), Stem bromelei
n), Ficin, Cathepsin B (C
athepsin B), chymopapain (Chymo
papain) and streptococcal proteinase (5treptococcal proteinase
e) is exemplified.
これらの酵素は蛋白質に対する加水分解時の特異性がか
なり広く、極めて多数のペプチド結合、アミド結合およ
びエステル結合を切断し、またベンゾイル−アルギニン
アミド、ベンゾイルグリシルロイシルグリシン、ベンゾ
イルチロシングリシンアミド等を比較的よく分解し、エ
キソ・エンドーペプチターゼの両件用を有する( J、
R,KimmelおよびE、 L。These enzymes have a fairly wide specificity when hydrolyzing proteins, and can cleave a large number of peptide bonds, amide bonds, and ester bonds, and also cleave benzoyl-argininamide, benzoylglycyleucylglycine, benzoyltyrosine glycinamide, etc. It is efficiently degraded and has both exo and endopeptidase functions (J,
R, Kimmel and E, L.
Sm1th、Advance Enzymology、
Vol 19.267(1957))。Sm1th,Advance Enzymology,
Vol 19.267 (1957)).
出発物質として使用される一般弐X−A−OH(式中X
は末端アミノ基の保護基であり、Aはアミノ酸残基また
はペプチド残基である)で示されるアミノ酸またはペプ
チドは前記(1)〜(4)の既知方法に示される(I)
に相当する化合物であり、本明細書では以下この化合物
を酸成分という。The general 2X-A-OH used as a starting material (in the formula
is a protecting group for the terminal amino group, and A is an amino acid residue or a peptide residue) The amino acid or peptide represented by (I) is shown in the known methods (1) to (4) above.
In this specification, this compound is hereinafter referred to as an acid component.
酸成分においてAはアミノ酸およびそのペプチドの残基
を意味し、アミノ酸としてはペプチド合成の分野で使用
されるグリシン、アラニン、バリン、ノルバリン、ロイ
シン、インロイシン、ノルロイシンのようなモノアミノ
モノカルボン酸、セリン、スレオニン、ホモセリンのよ
うなオキシアミノ酸、メチオニン、側鎖官能基の保護さ
れたシスチン又はシスティンのようなイオウを含むアミ
ノ酸、側鎖カルボキシル基の保護されたアスパラギン酸
又はグルタミン酸のようなモノアミノジカルボン酸、(
側鎖ア□)基の保護された)オルニチン、リジン又はア
ルギニンのようなジアミノモノカルボン酸などの脂肪族
アミノ酸並にフェニルアラニン、チロシンのような芳香
族核またはヒスチジン、トリプトファンの如き複素環を
もつアミノ酸が例示され、本明細書ではこの分野で通常
使用される略号により表示され、ペプチドについても同
様である。In the acid component, A means an amino acid and its peptide residue, and examples of the amino acid include monoamino monocarboxylic acids such as glycine, alanine, valine, norvaline, leucine, inleucine, and norleucine, which are used in the field of peptide synthesis; Oxyamino acids such as serine, threonine, homoserine, methionine, sulfur-containing amino acids such as cystine or cysteine with side chain functional groups, monoamino dicarboxylic acids such as aspartic acid or glutamic acid with side chain carboxyl groups protected. acid,(
Aliphatic amino acids such as diaminomonocarboxylic acids such as ornithine, lysine or arginine with protected side chain a□) groups, and amino acids with aromatic nuclei such as phenylalanine and tyrosine or heterocycles such as histidine and tryptophan. are exemplified and indicated herein by abbreviations commonly used in this field, and the same applies to peptides.
酸成分の遊離末端アミノ基に対する保護基としては第3
級アルコキシカルボニル、たとえば第3級ブチルオキシ
カルボニル(Boc−)、第3級アミルオキシカルボニ
ル(t −Aoc−)、など置換または非置換ベンジル
オキシカルボニル、たとえばベンジルオキシカルボニル
(Z−)、p−メトキシベンジルオキシカルボニル(P
MZ−)、3・5−ジメトキシベンジルオキシカルボニ
ル
(Z (OMe )2 )、2−4・6−)リメチル
ベンジルオキシ力ルボニル(TMZ−)、p−フェニル
アゾベンジルオキシカルボニル(PZ−)、p−)ルエ
ンスルホニル(Tos−)、o−ニトロフェニルスルフ
ェニル(Nps −)などが代表的な例として挙げられ
る。As a protecting group for the free terminal amino group of the acid component, a tertiary
substituted or unsubstituted benzyloxycarbonyl, such as benzyloxycarbonyl (Z-), p-methoxy Benzyloxycarbonyl (P
MZ-), 3,5-dimethoxybenzyloxycarbonyl (Z (OMe)2), 2-4,6-)limethylbenzyloxycarbonyl (TMZ-), p-phenylazobenzyloxycarbonyl (PZ-), Representative examples include p-)luenesulfonyl (Tos-) and o-nitrophenylsulfenyl (Nps-).
酸成分は遊離酸として反応系に添加されるが、反応系の
pH条件において電離しうる塩として添加されてもよい
。The acid component is added to the reaction system as a free acid, but may also be added as a salt that can be ionized under the pH conditions of the reaction system.
一方の出発物質として使用される一般式
H−B−Yで示されるア□ノ酸またはペプチドは前記(
1)〜(4)の既知方法で示される(n)の化合物に相
当する化合物であり、本明細書では以下アミン成分とい
い、BはAと同一のまたは異なるアミノ酸またはペプチ
ドの残基な示す。The amino acid or peptide represented by the general formula H-BY used as one of the starting materials is the above-mentioned (
It is a compound corresponding to the compound (n) shown by the known methods of 1) to (4), hereinafter referred to as an amine component, and B is the same or different amino acid or peptide residue from A. .
アミン成分におけるカルボキシル基の保護基としては、
第3級アルコキシ基、たとえば第3級ブトキシ(−0B
u−t)、置換または非置換ベンジルオキシ基たとえば
ベンジルオキシ(−()Bzl)、置換または非置換ベ
ンズヒドリルオキシ基たとえばベンズヒドリルオキシ(
−0Bh)、置換または非置換ベンジルアミノ基たとえ
ば2・4−ジメトキシベンジルアミノ(−NHDMB)
、置換または非置換ベンズヒドリルアミノ基たとえばベ
ンズヒドリルアミノ(−NHBh )等を用いる。As a protecting group for the carboxyl group in the amine component,
Tertiary alkoxy groups, such as tertiary butoxy (-0B
u-t), a substituted or unsubstituted benzyloxy group such as benzyloxy (-()Bzl), a substituted or unsubstituted benzhydryloxy group such as benzhydryloxy (
-0Bh), a substituted or unsubstituted benzylamino group such as 2,4-dimethoxybenzylamino (-NHDMB)
, a substituted or unsubstituted benzhydrylamino group such as benzhydrylamino (-NHBh).
これらのアミン成分のカルボキシル末端の保護基は、本
発明で用いる酵素すなわちチオールプロテイナーゼに属
する酵素たとえばパパインがエステラーゼおよびアミダ
ーゼ作用を伴うため、このような作用を受けないもので
あることを要する。The protecting group at the carboxyl terminal of these amine components must be free from esterase and amidase effects, since the enzymes used in the present invention, ie, enzymes belonging to thiol proteinases, such as papain, are associated with esterase and amidase effects.
本発明で用いる酸成分及びアミン成分はすでに述べたこ
とから明らかな様にアミノ酸又はペプチド残基の側鎖に
官能基のある場合を含むものである。As is clear from the above, the acid component and amine component used in the present invention include cases where the side chain of the amino acid or peptide residue has a functional group.
この場合これらの官能基を保護するのが望ましいことが
多く、その保護基としては、ω−アミノ基(N″J)の
保護にはN(″)−ベンジルオキシカルボニル(No)
−Z)、t−ブトキシカルボニル(N(1′)−BOC
)及びトシル(N”−TO8)などを、アルギニンのN
−グアニジノ基(N’)の保護にはニトロ基のほかNG
−ベンジルオキシカルボニル(N’−Z)およびNo・
No−ジベンジルオキシカルボニル(No−Z−Z)な
どを、イミダゾール核(N1m)の保護にはN1m −
ベンジル(Nim−BZl)及びトシル(Nim−TO
8)などを、ω−カルボキシル基の保護にはω−ベンジ
ルオキシ(−OBzl)などを、またオキシアミノ酸の
水酸基が保護される必要のある場合には脂肪族、芳香族
アミノ酸の別なく、0−エーテル型、たとえば0−ベン
ジル基(OBzl)などを使用することができる。In this case, it is often desirable to protect these functional groups, and the protecting groups include N(″)-benzyloxycarbonyl (No) to protect the ω-amino group (N″J).
-Z), t-butoxycarbonyl (N(1')-BOC
) and tosyl (N”-TO8), etc., to the N of arginine.
-To protect the guanidino group (N'), in addition to the nitro group, NG
-benzyloxycarbonyl (N'-Z) and No.
No-dibenzyloxycarbonyl (No-Z-Z), etc., and N1m − to protect the imidazole nucleus (N1m).
Benzyl (Nim-BZl) and tosyl (Nim-TO
8), etc., to protect the ω-carboxyl group, use ω-benzyloxy (-OBzl), and when the hydroxyl group of an oxyamino acid needs to be protected, regardless of whether it is an aliphatic or aromatic amino acid, use 0. -Ether types such as 0-benzyl group (OBzl) can be used.
システィンのメルカプト基のS−保護基としてはS−ベ
ンジル基(SBzl)などが使用できる。As the S-protecting group for the mercapto group of cysteine, an S-benzyl group (SBzl) or the like can be used.
本明細書でいう保護基は少なくとも導入された基が反応
に際して安定であることおよび生成物から容易に脱離で
き、その脱離の際に副反応を生起しないことの条件を満
すことが必要である。The protecting group referred to in this specification must at least satisfy the conditions that the introduced group is stable during the reaction, can be easily removed from the product, and does not cause any side reactions during the removal. It is.
出発物質の酸成分およびアミン成分は前記の保護基を有
するほか、ア□ン成分のN″−アミノ基は遊離の場合は
勿論、塩酸塩、臭化水素酸塩、しユウ酸塩、p−1ルエ
ンスルホン酸塩および酢酸塩などの無機または有機酸塩
の形態のいずれのものを使用してもよい。In addition to the acid component and amine component of the starting material having the above-mentioned protecting groups, the N''-amino group of the amine component may be free, as well as hydrochloride, hydrobromide, oxalate, p- Any inorganic or organic acid salt form may be used, such as 1-luenesulfonate and acetate.
本発明においてペプチド結合を生成する脱水縮合反応は
水性溶液中、本発明で用いる酵素が酵素活性を示すpH
の範囲で実施することが必要である。In the present invention, the dehydration condensation reaction to generate peptide bonds is performed in an aqueous solution at a pH at which the enzyme used in the present invention exhibits enzymatic activity.
It is necessary to implement this within the scope of.
この範囲はほぼpH4乃至7.5程度の範囲である。This range is approximately pH 4 to 7.5.
本発明を工業的に実施する際、反応溶液のpHをこの範
囲に保つために反応装置に反応液のpHを検出する手段
と酸又は塩基を供給する手段とを設け、検出した反応液
のpHに応じて、これに酸又は塩基を供給し、これによ
り、反応液のpHを所望の範囲に保つ。When carrying out the present invention industrially, in order to maintain the pH of the reaction solution within this range, the reaction apparatus is equipped with a means for detecting the pH of the reaction solution and a means for supplying an acid or base, and the detected pH of the reaction solution is Depending on the conditions, an acid or a base is supplied to this to maintain the pH of the reaction solution within a desired range.
具体的には検出した反応溶液のpHに応じて、これに調
節された量の塩基を供給し、pHが7.5程度を超えた
場合には酸を供給する。Specifically, a controlled amount of base is supplied depending on the detected pH of the reaction solution, and when the pH exceeds about 7.5, acid is supplied.
出発物質は一般にアミン成分1モルに対して酸成分0.
8〜2モル好ましくは1〜1.5モルの割合で用いるこ
れらの出発物質が水性溶媒に溶は難い場合にはメタノー
ル、エタノールのようなアルコール、ジメチルホルムア
ミド、ジオキサン、テトラヒドロフラン、ジメチルスル
ホキシド等の溶媒を加えてその溶解性を改善することが
できる。The starting materials are generally 0.00% acid component per mole amine component.
When these starting materials used in a ratio of 8 to 2 moles, preferably 1 to 1.5 moles, are difficult to dissolve in aqueous solvents, solvents such as alcohols such as methanol and ethanol, dimethylformamide, dioxane, tetrahydrofuran, and dimethyl sulfoxide are used. can be added to improve its solubility.
この場合その添加量は本発明の酵素反応を阻害しない程
度に止める必要があり、通常水1重量部に対して溶媒1
重量部以下を用いる。In this case, it is necessary to limit the amount added to an extent that does not inhibit the enzyme reaction of the present invention, and usually 1 part by weight of water to 1 part by weight of solvent.
Use parts by weight or less.
本発明の反応は水性溶媒中で進行し、反応生成物が相対
的にこれに対する溶解度の小さくなる系であることが必
要で、好ましくは反応生成物が難溶または不溶となる系
である。The reaction of the present invention proceeds in an aqueous solvent, and the reaction product must have a relatively low solubility therein, preferably a system in which the reaction product is poorly soluble or insoluble.
反応に要する酵素量はアミン成分1mmolに対して1
0〜400■、望ましくは50〜300即である。The amount of enzyme required for the reaction is 1 for 1 mmol of amine component.
0 to 400 mm, preferably 50 to 300 mm.
また溶液中に酵素の活性化剤としてシスティン若くはそ
の塩または2−メルカプトエタノール若くはその塩など
を添加してもよい。Further, cysteine or a salt thereof, 2-mercaptoethanol or a salt thereof, etc. may be added to the solution as an enzyme activator.
反応温度は酵素活性を維持する観点から一般には20〜
55℃、望ましくは30〜40℃である。The reaction temperature is generally 20~20°C from the viewpoint of maintaining enzyme activity.
The temperature is 55°C, preferably 30-40°C.
前記の条件で反応を実施することにより、反応は円滑に
進行し、通常1〜24時間で完結する。By carrying out the reaction under the above conditions, the reaction proceeds smoothly and is usually completed in 1 to 24 hours.
生成物は反応系外に析出するので、容易に単離すること
ができる。Since the product precipitates outside the reaction system, it can be easily isolated.
本発明を更に具体的に説明すると、チオールプロテイナ
ーセに属する酵素、たとえばパパインを用いて前記一般
式X−A−B−Yにおいて示される最も小さなペプチド
すなわちジペプチドを容易に製造することができる。To explain the present invention more specifically, the smallest peptide, ie, dipeptide represented by the general formula XABY can be easily produced using an enzyme belonging to thiol proteinase, such as papain.
たとえばに示されるようにリジルリジンのようなジペプ
チドを製造する場合6位アミノ基をカルボベンゾキシル
基(2−)で保護したリジンより得た2−誘導体を酸成
分、又t−ブチルエステルをアミン成分として上記の方
法を適用するとぎ、側鎖アミノ基の保護されたリジルリ
ジンを得ることができる。For example, when producing a dipeptide such as lysyl lysine, the 2-derivative obtained from lysine with the 6-position amino group protected with a carbobenzoxyl group (2-) is used as the acid component, and the t-butyl ester is used as the amine component. By applying the above method, lysyl lysine with a side chain amino group protected can be obtained.
又アルギニンを含むジペプチドとしてアルギニルロイシ
ンの場合
すなわち、アルギニンのグアニル基及びアミノ基なZで
保護した)IJ−Z−アルギニンを酸成分として又アミ
ン成分としてはロイシンのベンツヒドリルエステルを用
いてパパインの存在下反応させるとジペプチド誘導体を
容易に得ることができる。In the case of arginylleucine as a dipeptide containing arginine, IJ-Z-arginine (protected with Z, which is the guanyl group and amino group of arginine) is used as the acid component, and as the amine component, benzhydryl ester of leucine is used to prepare papain. A dipeptide derivative can be easily obtained by reacting in the presence of the dipeptide.
又側鎖に官能基を有するア□ノ酸の場合、上記の二側の
ようにこれを保護して反応を行うか、又は無保護のまま
反応を行うこともできる。In the case of an anoic acid having a functional group in its side chain, the reaction can be carried out with it protected as in the case of the above two sides, or the reaction can be carried out without protection.
ヒスチヂンを例にとれば
(イ)が側鎖保護、(ロ)が無保護の例に和尚するがパ
パインを用いて反応を行うといづれの場合にも良好な結
果が得られた。Taking histidine as an example, (a) is an example with side chain protection, and (b) is an unprotected example, but good results were obtained in both cases when the reaction was carried out using papain.
以上ジペプチドについて述べたが酸成分がペプチド結合
を1ケ所含む場合すなわち、アシルジペプチドとア□ノ
酸アミド誘導体の反応もパパインによって副反応を伴う
ことなく進行する。As described above regarding dipeptides, when the acid component contains one peptide bond, that is, the reaction between the acyl dipeptide and the amino acid amide derivative also proceeds due to papain without side reactions.
−例をあげれば
この場合にも反応は円滑に進行し、生成物としてカルボ
ベンゾキシ−プロリル−グリシル−ロイシン−ペンツヒ
ドリルアミドを得ることができた。- For example, the reaction proceeded smoothly in this case as well, and carbobenzoxy-prolyl-glycyl-leucine-penthydrylamide could be obtained as a product.
酸成分、アミン成分共にジペプチドの場合につ・。When both the acid component and the amine component are dipeptides.
・いて−例をあげれば、ペプチドホルモンとして知られ
ているVal 5−アンジオテンシン−■の3−6のテ
トラペプチドの合成に適用できる。- For example, it can be applied to the synthesis of the 3-6 tetrapeptide of Val 5-angiotensin-■, which is known as a peptide hormone.
すなわち
アミン成分としてパリルーヒスチジンエステルを用いパ
パイン存在下反応を行なうとこの場合は生成物としてテ
トラペプチドのベンジルエステル基が脱離したものが得
られる。That is, when a paryl-histidine ester is used as the amine component and the reaction is carried out in the presence of papain, a product is obtained in which the benzyl ester group of the tetrapeptide is eliminated.
これらはパパインの性質の1つであるエステラーゼ作用
を受けた結果であると考えられる。These are thought to be the result of esterase action, which is one of the properties of papain.
このような反応はペプチド合成の計画でこのテトラペプ
チドを次に酸成分として予定している場合には極めて好
都合である。Such a reaction is extremely advantageous when a peptide synthesis plan envisages this tetrapeptide as the next acid component.
本発明は前記から明らかなようにエステラーゼおよびア
ミダーゼ作用を伴うチオールプロテイナーゼに属する酵
素を使用するにもかΣわらず、酸成分のカルボキシル保
護基として前述の特定の基を選択することによりオリゴ
ペプチド・ポリペプチドの合成を可能にした点で特異な
効果を奏するものである。As is clear from the above, although the present invention uses enzymes belonging to thiol proteinases with esterase and amidase actions, oligopeptides and It has a unique effect in that it enables the synthesis of polypeptides.
次に本発明を更に詳細な実施例について説明するが本発
明はこれにより伺等限定されるものではない。Next, the present invention will be described in more detail with reference to embodiments, but the present invention is not limited thereto.
実施例 I
Z −Glm −OH280,2■(1mmol )及
びH−Phe −Phe−OBut368.5771(
1mmol)をフラスコで水10TrLlに懸濁した。Example I Z -Glm -OH280,2 (1 mmol) and H-Phe -Phe-OBut368.5771 (
1 mmol) was suspended in 10 TrLl of water in a flask.
これにpHメーターのガラス電極を挿入し水酸基ナトリ
ウム水溶液(1/10規定)を滴下してpHを約5,0
に調節しながらパパイン1507Q及び2−メルカプト
エタノールo、i mlを添加しフラスコを振盪して固
形分を溶解させた。Insert the glass electrode of a pH meter into this and drop a sodium hydroxide aqueous solution (1/10 normal) to adjust the pH to approximately 5.0.
o. im ml of papain 1507Q and 2-mercaptoethanol were added while adjusting the temperature, and the flask was shaken to dissolve the solids.
これを38℃で20時間振盪して反応させた。This was shaken and reacted at 38° C. for 20 hours.
この間ガラス電極pHメーターにより反応液のpHを測
定し、水酸化ナトリウム水溶液(1/10規定)を添加
して反応液のpHを5乃至6に保持した。During this time, the pH of the reaction solution was measured using a glass electrode pH meter, and an aqueous sodium hydroxide solution (1/10 normal) was added to maintain the pH of the reaction solution at 5 to 6.
析出した結晶を日別し、水、希塩酸(1規定)、水、ア
ンモニア水(7%)及び水で順次洗浄後乾燥した。The precipitated crystals were separated daily, washed successively with water, dilute hydrochloric acid (1N), water, aqueous ammonia (7%) and water, and then dried.
これを酢酸エチルより再結晶し、m、p、197〜20
0°Cを有するZ −Glm −Phe −Phe−O
But510■を得た。This was recrystallized from ethyl acetate, m, p, 197-20
Z-Glm-Phe-Phe-O with 0 °C
But510 ■ was obtained.
収率80,8%。実施例 2
Z −Phe −Val −OH398,5m9及びH
Phe −Val−OBut320.4 m9をフラス
コ中で水10m1に懸濁した。Yield 80.8%. Example 2 Z-Phe-Val-OH398,5m9 and H
320.4 m9 of Phe-Val-OBut was suspended in 10 ml of water in a flask.
次いでこれにpHメーターのガラス電極を挿入し希塩酸
で系のpHを約4.55.0に調節しながら、パパイン
150即及び2メルカプトエタノール0.1 mlを添
加し、フラスコを振盪して固形分を溶解させ、これを3
8℃で20時間振盪して反応させた。Next, a glass electrode of a pH meter was inserted into this, and while adjusting the pH of the system to approximately 4.55.0 with dilute hydrochloric acid, 0.1 ml of papain 150 and 2 mercaptoethanol was added, and the flask was shaken to reduce the solid content. Dissolve this and add 3
The mixture was shaken and reacted at 8°C for 20 hours.
この間ガラス電極pHメーターにより反応液のpHを測
定し、塩酸を添加して反応液のpHを4.5乃至5.0
に保持した。During this time, the pH of the reaction solution was measured using a glass electrode pH meter, and hydrochloric acid was added to adjust the pH of the reaction solution to 4.5 to 5.0.
was held at
析出した結晶を戸別し、水、希塩酸(1規定)、水、ア
ンモニア水(7%)及び水で順次洗浄後乾燥した。The precipitated crystals were separated from each other, washed successively with water, dilute hydrochloric acid (1N), water, aqueous ammonia (7%), and water, and then dried.
これを酢酸エチル・石油エーテルで再結晶してm、p、
130〜145℃を有するZ −PheVal −Ph
e −Val−OBut3 Qm9を得た。This was recrystallized from ethyl acetate/petroleum ether to give m, p,
Z-PheVal-Ph with 130-145°C
e-Val-OBut3 Qm9 was obtained.
収率4.3%。Yield 4.3%.
Claims (1)
般弐X−A−OH(式中Xは末端アミノ基の保護基であ
り、Aはアミノ酸残基またはペプチド残基である)で示
されるN末端に保護基を有するア□ノ酸またはペプチド
と、一般式H−B−Y(式中Yは、第3級アルコキシ基
、置換または非置換ベンジルオキシ基、置換または非置
換ベンジルア□)基、置換または非置換ベンズヒドリル
オキシ基および置換または非置換ベンズヒドリルアミノ
基よりなる群から選ばれた末端カルボキシル基の保護基
であり、BはAと同一のまたは異なるアミノ酸残基また
はペプチド残基である)で示されるC末端に保護基を有
するアミノ酸もしくはペプチドとを、反応液のpHを検
出する手段と、反応液のpHを調節するために酸又は塩
基を反応液に添加する手段を備えた反応装置中で、水性
溶液中チオールプロテイナーゼが酵素活性を示すpHの
範囲内において反応させることを特徴とする一般弐X−
A−B−Y(式中、X、A、B、Yは前記定義と同一で
ある)で示されるペプチドの製造方法。1 In the presence of an enzyme belonging to thiol proteinase, the N-terminus is protected by a general 2X-A-OH (wherein X is a terminal amino group protecting group and A is an amino acid residue or a peptide residue) an anoic acid or a peptide having the general formula H-B-Y (wherein Y is a tertiary alkoxy group, a substituted or unsubstituted benzyloxy group, a substituted or unsubstituted benzyloxy group), a substituted or unsubstituted benzyloxy group, A protecting group for a terminal carboxyl group selected from the group consisting of a substituted benzhydryloxy group and a substituted or unsubstituted benzhydryl amino group, and B is the same or different amino acid residue or peptide residue as A) A reaction device equipped with means for detecting the pH of a reaction solution, and means for adding an acid or base to the reaction solution in order to adjust the pH of the reaction solution. Among them, the general 2-X-
A method for producing a peptide represented by A-BY (wherein X, A, B, and Y are the same as defined above).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10018776A JPS5834120B2 (en) | 1976-08-24 | 1976-08-24 | Method for producing peptides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10018776A JPS5834120B2 (en) | 1976-08-24 | 1976-08-24 | Method for producing peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5326392A JPS5326392A (en) | 1978-03-11 |
| JPS5834120B2 true JPS5834120B2 (en) | 1983-07-25 |
Family
ID=14267291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10018776A Expired JPS5834120B2 (en) | 1976-08-24 | 1976-08-24 | Method for producing peptides |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5834120B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6027519B2 (en) * | 1977-11-02 | 1985-06-29 | 塩野義製薬株式会社 | New synthesis method for peptide derivatives |
-
1976
- 1976-08-24 JP JP10018776A patent/JPS5834120B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5326392A (en) | 1978-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4256836A (en) | Addition compound of dipeptide derivative and amino acid derivative | |
| US4339534A (en) | Process for enzymatic production of peptides | |
| US4086136A (en) | Process for producing a peptide using a serine or thiol proteinase | |
| US4119493A (en) | Process for producing a peptide | |
| US5304470A (en) | Process for the enzymatic preparation of protected and unprotected di- and oligopeptides in aqueous solutions | |
| US4116768A (en) | Process for producing a peptide | |
| US5032675A (en) | Process for the production of glutamine derivatives | |
| US3972773A (en) | Process for producing peptide | |
| CN101027315B (en) | Method for the synthesis and selective biocatalytic modification of peptides, peptide mimetics and proteins | |
| Saltman et al. | Co‐oligopeptides of aromatic amino acids and glycine with variable distance between the aromatic residues. VII. Enzymatic synthesis of N‐protected peptide amides | |
| EP0149594A2 (en) | Enzymatic coupling of n-formyl amino acids and/or peptide residues | |
| Pellegrini et al. | Pepsin‐catalyzed peptide synthesis | |
| JPS5834120B2 (en) | Method for producing peptides | |
| CA1059938A (en) | Process for producing a peptide | |
| JP2641464B2 (en) | Enzymatic peptide bond formation reaction | |
| JPS5813158B2 (en) | Method for producing peptides | |
| JPS625994A (en) | Production of lysine derivative | |
| JPS5837840B2 (en) | Method for producing peptides | |
| Bizzozero et al. | Enzyme‐Catalyzed Peptide‐Bond Formation: Elastase‐and δ‐Chymotrypsin‐Assisted Synthesis of Oligopeptides | |
| US3790618A (en) | N omega-4,4-dimethoxybenzhydryl derivatives of asparagine and glutamine | |
| CA1177429A (en) | Process for enzymatic production of peptides | |
| JPH01228496A (en) | Enzymatic synthesis of peptide | |
| JPH01199595A (en) | Enzymatic production of dipeptide | |
| Becker et al. | The effect of homologous amino acid replacement on the conformation of oligopeptides. I. Synthesis of co‐oligopeptides containing methionine and valine | |
| JPS63254994A (en) | Production of n-substituted leucine enkephalinamide |